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Abstract 
Notch signaling plays a key role in many cell fate decisions during development by directing 
different gene expression programs via the transcription factor CSL, known as Su(H) in 
Drosophila. Which target genes are responsive to Notch signaling is influenced by the 
chromatin state of enhancers, yet how this is regulated is not fully known. Detecting a 
specific increase in the histone variant H3.3 in response to Notch signaling, we tested which 
chromatin remodelers or histone chaperones are required for the changes in enhancer 
accessibility to Su(H) binding. We show a crucial role for the Brahma SWI/SNF chromatin 
remodeling complex, including the actin-related BAP55 subunit, in conferring enhancer 
accessibility and enabling the transcriptional response to Notch activity. The Notch-
responsive regions have high levels of nucleosome turnover which depend on the Brahma 
complex, increase in magnitude with Notch signaling and primarily involve histone H3.3. 
Together these results highlight the importance of SWI/SNF-mediated nucleosome turnover 
in rendering enhancers responsive to Notch. 




Many cell fate decisions during development are directed by Notch signaling between 
neighboring cells, and misregulation of the pathway results in a variety of complex diseases 
[1,2]. Notch, the receptor, becomes cleaved upon binding to cell-surface ligands, freeing the 
Notch intracellular domain (NICD) to travel directly to the nucleus and activate target gene 
expression. Depending on the context, different genes are targeted by the Notch 
transcription complex due to differential enhancer accessibility [3–5]. Furthermore, 
successful activation involves largescale changes in histone modifications and chromatin 
accessibility across the target enhancers [4,6–8]. How these changes in chromatin structure 
are brought about remains to be determined. 
The conserved DNA binding partner of NICD is known as Suppressor of Hairless (Su(H)) in 
Drosophila melanogaster or CSL more generally. In the absence of Notch activity, Su(H) 
partners with co-repressive proteins to prevent transcription, often acting on the same 
genes which are induced upon Notch signal activation [5]. The switch from genes being 
repressed (Notch-OFF) to activated (Notch-ON) involves a change in the dynamics of Su(H) 
binding, so that it acquires a longer residence time when participating in the activating 
complex, as well as increased accessibility of the DNA [8]. Several histone acetyltransferases 
and methyltransferases contribute to this switch [8–10] and their actions could explain 
some of the changes in histone post-translational modifications that have been observed 
[4,6,7]. However, the histone modifiers that have been identified do not explain how target 
enhancer accessibility is regulated, making it likely that other factors contribute. 
One way that chromatin structure can be altered is by a change in the density or dynamics 
of the nucleosomes, coordinated by chromatin remodeling complexes which fall into four 
categories based on the classification of their ATPase domains: Imitation Switch (ISWI), 
Chromodomain helicase DNA-binding (CHD), Inositol-Requiring Protein 80 (INO80) and 
Switching-Defective/Sucrose Non-Fermenting (SWI/SNF) complexes [11–13]. Their common 
property of DNA translocation provides the force needed to dislodge histone-DNA contacts 
and is tailored to achieve nucleosome repositioning, sliding, ejection or editing depending 
on the complex [14]. Chromatin remodeling has been shown to facilitate gene expression in 
a variety of contexts. For example, INO80 is recruited by Oct4 at pluripotency genes to 
maintain their accessibility in ES cells [15], and by reducing nucleosome occupancy, it 
facilitates oncogene transcription in melanoma [16]. Similarly, SWI/SNF remodelers 
establish accessible enhancers in fibroblasts following their recruitment by lineage-specific 
transcription factors and FOS/JUN [17], and function to shift nucleosomes away from GATA1 
sites in hematopoietic stem cells allowing TAL1-dependent transcription [18]. Conversely, in 
some cases chromatin remodeling can be inhibitory, such as at the MMLV promoter where 
SWI/SNF recruitment by the glucocorticoid receptor (GR) subsequently inhibits GR binding 
[19,20]. These diverse roles are highlighted by the fact that mutations affecting remodeling 
complexes can both promote and suppress tumor progression [11,21]. 
The contribution made by chromatin remodeling to Notch-dependent transcription is also 
unclear, as conflicting models have been proposed depending on the system and the type of 
analysis. For example, while two developmental studies based on genetics and phenotypic 
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analysis argued that SWI/SNF complexes contribute positively to Notch-dependent 
transcription [22,23], another proposed an inhibitory effect, detecting increased expression 
of a key target gene when SWI/SNF components were depleted [24]. Confounding the 
situation further, a non-nuclear effect on Notch trafficking was reported following depletion 
of Snr1, a member of SWI/SNF complexes in Drosophila [25]. It is possible that histone 
variants also play a role in regulating enhancer accessibility, and a recent study suggests that 
the acetylation of histone H2A.Z by Tip60 supports Notch-dependent gene expression [10]. 
However, none of these studies have analyzed the effects on chromatin dynamics directly, 
making it important to investigate how depletion of chromatin remodelers can bring about 
these effects on Notch-dependent transcription mechanistically. 
Given that enhancer accessibility appears to play a key role in Notch-mediated transcription, 
we set out to investigate the nucleosome dynamics at target enhancers and to distinguish 
which chromatin remodelers are critical for enabling target gene activation by Notch. Firstly, 
we find that Notch signaling regulates nucleosome turnover at target enhancers and 
promotes incorporation of the histone variant H3.3. Secondly, by testing several classes of 
chromatin remodelers, we find that the BRM SWI/SNF complex, including the actin-related 
BAP55 subunit, is required for nucleosome turnover and the enhancer accessibility required 
for the Notch response. Thus, SWI/SNF complexes are vital for the Notch response, and we 
propose a model whereby dynamic chromatin remodeling poises Notch-responsive genes 
and facilitates their rapid activation. 
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Results 
Ectopic Notch signaling increases the local concentration of histone H3.3 at the E(spl)-C 
Previous work has shown that Notch signaling promotes largescale changes in chromatin 
structure, including rapid increases in histone acetylation and increased chromatin 
accessibility [4,6–8]. In Drosophila, these changes have been most clearly observed at the 
Enhancer of split-Complex (E(spl)-C), a 60kb region where 11 highly Notch-responsive genes 
are concentrated [26–29]. We therefore chose to investigate whether there are any 
largescale changes in the histone variant H3.3 or canonical histone H3 occupancy at this 
region following Notch activation, making use of a live tag marking the E(spl)-C in Drosophila 
larval salivary glands [8]. Without Notch signaling, both histones H3.3-GFP and H3-GFP were 
present at low levels at the E(spl)-C compared to surrounding regions. However, when we 
activated Notch signaling in this tissue by expressing a constitutively-active form of the 
Notch receptor, NΔECD [30,31], under control of the GAL4/UAS system, the levels of H3.3-GFP 
were strongly increased compared to surrounding regions (Fig 1A, Notch-ON). This pattern 
was found to be reproducible when the relative fluorescence intensity was quantified across 
the locus in images taken from live salivary glands (Fig 1B). No such change was detected 
when we examined the effects on histone H3 in a similar manner (Fig 1C and D). 
Histone H3.3 has been associated with actively-transcribed genes and can be incorporated 
into the chromatin independently of DNA replication [32,33]. To verify that the Notch-
dependent increase in H3.3-GFP was replication-independent, we used a mutant form of 
histone H3.3, H3.3core-GFP, which is only incorporated in a replication-independent manner 
[32]. Indeed, with H3.3core-GFP we saw the same pattern as with H3.3-GFP (Fig 1E and F), 
suggesting that the local increase in histone H3.3 concentration at the E(spl)-C is not due to 
an increased level of endoreplication at this locus, and thus likely represents changes 
associated with Notch-induced transcription. Furthermore, when histone H3.3 tagged with 
another fluorophore, mKO, was expressed on a much shorter timescale under Notch-OFF 
and Notch-ON conditions, making use of a heat-shock-inducible FRT construct [34], the 
same pattern of incorporation was observed (Fig EV1). This showed that the incorporation 
of histone H3.3 under Notch-ON conditions is dynamic and ongoing during the period of 
Notch activity. 
 
The BRM chromatin remodeling complex is required for Notch-responsive accessibility 
The incorporation of histone H3.3 at Notch-regulated genes, along with the previously 
detected changes in accessibility [8], suggest an involvement of chromatin remodeling 
complexes and/or histone chaperones. In order to ascertain which of these are needed, we 
tested if any remodelers or chaperones are required for the recruitment of Su(H) to the 
E(spl)-C. We have previously shown that Notch activity promotes robust recruitment of 
Su(H)-GFP, detectable as a band of fluorescence when salivary gland nuclei are imaged live 
under conditions of UAS-NΔECD expression (Fig 2A) [8]. We therefore performed RNAi 
knockdown of different chromatin remodelers and histone chaperones and assessed the 
impact on Su(H) recruitment under these Notch-ON conditions. To verify that the RNAi lines 
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were effective, RNA was extracted from the salivary glands and expression levels quantified 
by reverse transcription-qPCR (Fig EV2A). Only those chromatin remodelers and chaperones 
where a reduced expression was detected were analyzed further. In the majority of cases 
we detected little or no change in Su(H) recruitment (Fig 2A and B). For example, 
knockdown of components in the ISWI, NuRD and INO80 complexes failed to perturb Su(H) 
recruitment (for review of chromatin remodelers in Drosophila, see [35]). Likewise, 
knockdown of chromatin assembly factors or H3.3-specific chaperones such as DEK [36] or 
Yemanuclein (YEM) [37] had no effect. In contrast, depletion of core components of the 
BRM (BAF/PBAF) SWI/SNF chromatin remodeling complex [38,39] had a striking effect. 
Knockdown of Moira (SMARCC1/2) eliminated visible recruitment of Su(H)-GFP in all nuclei, 
while knockdown of Snr1 (SMARCB1) prevented the formation of a single clear band of 
recruitment in most nuclei (Fig 2A-D). 
Expression of a commonly-used dominant negative form of the Brahma ATPase BrmK804R 
[40] had the same effect as Moira knockdown, preventing formation of the Su(H)-GFP band 
(Fig 2C and D). This demonstrates that the ATPase activity of the BRM complex is required 
for Su(H) recruitment. Furthermore, DNA staining of salivary gland nuclei showed that the 
chromosomes retained their characteristic DNA banding patterns, although the 
chromosomes were somewhat reduced in size (Fig EV2C). Thus, there was no global 
disruption to the nuclear architecture when BrmK804R was expressed, suggesting that the 
effects on Su(H) recruitment were specific. 
Two different BRM complexes have been reported, BAP and PBAP (BAF and PBAF), which 
are distinguished by specific subunits OSA (ARIID1A/B) in BAP or BAP170 (ARID2) and 
Polybromo (PBRM1) in PBAP [38,39]. Surprisingly, these subunits do not appear to be 
essential for Notch-dependent Su(H) recruitment. A robust band of Su(H)-GFP was still 
detectable in nuclei depleted for OSA, BAP170 or Polybromo (Fig 2C and D), even though 
little or no detectable RNA or protein remained (Fig EV2B, D-G). This suggests that either the 
two complexes can compensate for each other or that the specialized subunits are not 
necessary for the Notch-mediated effects on chromatin. 
Su(H) recruitment in the Notch-ON condition correlates with increased chromatin 
accessibility [8]. We therefore used the assay for transposase-accessible chromatin (ATAC) 
[41] to determine whether the BRM complex is required for this Notch-induced change, 
using qPCR to analyze different regions of the E(spl)-C (chosen regions illustrated in Fig 3A). 
Expression of BrmK804R had a very localized effect on accessibility measured with ATAC, 
causing a strong reduction at the E(spl)mβ-HLH and E(spl)m3-HLH enhancer regions in both 
Notch-OFF (Fig 3B) and Notch-ON (Fig 3C) conditions. The effects in the Notch-ON condition 
were the most dramatic, with BrmK804R largely abolishing the increases in accessibility 
induced by Notch across the E(spl)-C so that the locus resembled that in the Notch-OFF 
condition. 
To determine whether the BRM complex plays the same role at other inducible enhancers, 
several additional regions were analyzed, including heat-shock and ecdysone-responsive 
regions. In contrast to the Notch-responsive regions in the E(spl)-C, the ecdysone-responsive 
regions of Hr4, Dip-B and Eip75B showed no decrease in accessibility in the presence of 
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BrmK804R (Fig EV3A and B) and, unlike E(spl)mβ-HLH and E(spl)mα-HLH, there was no 
decrease in transcription of these genes (Fig EV3C). Surprisingly, two heat-shock promoters 
underwent an increase in accessibility when BrmK804R was expressed (Fig EV3A and B). 
These data suggest that SWI/SNF chromatin remodeling complexes are differentially 
deployed depending on the regulatory mechanisms operating, and demonstrate that there 
is some specificity in the role that BRM complexes play at Notch-regulated loci. 
To rule out the possibility that the effects of BrmK804R on accessibility at the E(spl)-C were 
indirect, resulting from a reduced Su(H) recruitment, we knocked down Su(H) with RNAi in 
the Notch-OFF condition and performed ATAC. The knockdown was effective in removing all 
detectable Su(H)-GFP when salivary glands were imaged live (Fig EV3D), and these 
conditions resulted in an increased accessibility across the E(spl)-C (Fig 3D). This increase in 
accessibility is consistent with the known role of Su(H) as a repressor of target genes in the 
absence of Notch signaling and contrasts with the consequences of inhibiting the BRM 
complex. 
Together these results demonstrate that the BRM complex is necessary to maintain a 
degree of accessibility at enhancers, even before the cells experience Notch signaling, and is 
then essential for the Notch activity-dependent increase in accessibility of the E(spl)-C. 
 
The BRM complex is required for acute Notch responses in Kc167 cells 
To test the role of the BRM complex in a system where we could acutely manipulate Notch 
activity, we turned to Drosophila Kc167 cells. In these cells, Notch signaling is rapidly 
activated by the addition of the calcium chelator EGTA, which by destabilizing the negative 
regulatory region, elicits the rapid cleavage of the Notch receptor and activates target genes 
within 30 minutes [4,28,42]. As in the salivary gland, gene activation is accompanied by an 
increase in Su(H) recruitment, detectable by chromatin immunoprecipitation (ChIP) [4]. To 
test the involvement of the BRM complex in this context, we performed RNAi for two core 
components of the BRM complex, Brm and Snr1 (Fig 4A), and analyzed the effects on Su(H) 
recruitment by ChIP with qPCR. Both in Notch-OFF (Fig 4B) and Notch-ON (EGTA treatment, 
Fig 4C) cells, the level of Su(H) recruitment was decreased when Brm or Snr1 were depleted 
by RNAi, showing that the BRM complex is essential for Su(H) recruitment. The transcription 
of the target genes E(spl)mβ-HLH and E(spl)m3-HLH, which are usually strongly induced 
following Notch activation, was also decreased by brm RNAi (Fig 4D). 
In order to confirm that the ATPase activity of the BRM complex was essential, we made 
stable cell lines expressing BrmK804R or the wild type form, BrmWT as a control (under 
control of the copper-inducible pMT promoter) [43]. Expression of E(spl)mβ-HLH and 
E(spl)m3-HLH was rapidly upregulated by EGTA-induced Notch activation in control 
conditions (Fig 4E, left). However, following copper-induced expression of BrmK804R for 24 
hours, cells had a significantly reduced upregulation of E(spl)mβ-HLH and E(spl)m3-HLH 
compared to cells expressing BrmWT (Fig 4E, right). This shows that the ATPase function of 
the BRM complex is key to the Notch response in these cells. 
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Another sub-complex associated with SWI/SNF chromatin remodelers contains actin-related 
proteins (ARPs) and is proposed to facilitate sliding and ejection of nucleosomes [44–46]. To 
test whether this sub-complex is important for the activity of Notch-responsive enhancers, 
we analyzed the effects from knocking down the Drosophila ARP homolog, BAP55, in Kc167 
cells. Strikingly, this had similar consequences to depletion of the core Brm and Snr1 
subunits. Firstly, Su(H) recruitment was decreased both in Notch-OFF and Notch-ON 
conditions (Fig 4F), and secondly, Notch-induced RNA levels were reduced (Fig 4G). These 
results demonstrate an essential role for BAP55 in the Notch response and, given the data 
that ARPs are required for histone ejection [46], suggest that this aspect of SWI/SNF 
function is important mechanistically for Notch enhancer activation. 
 
Nucleosome turnover increases with Notch signaling and is dependent on the BRM 
complex 
Chromatin remodelers are thought to slide, replace or eject nucleosomes [13]. Even the 
short pulse of activity in Kc167 cells was sufficient to bring about a change in chromatin 
accessibility measured with ATAC (Fig EV3E), suggesting that the BRM complex could be 
moving or depleting histones at the Notch-regulated enhancers. Additionally, the histone 
variant H3.3 has been associated with nucleosome turnover [47,48]. Given the results 
showing changes in accessibility and histone H3.3 levels, and the involvement of BAP55, we 
were prompted to measure whether nucleosome turnover was occurring. To do this we 
used the CATCH-IT technique, which relies on the incorporation of a methionine analog 
called azidohomoalanine into newly-synthesized proteins [49,50]. Click chemistry is used to 
biotinylate this residue so that any chromatin containing newly-synthesized proteins can 
therefore be isolated, and a wash with high salt and urea leaves only the histone H3/H4 
tetramers bound to the DNA such that histone turnover is distinguished from the 
incorporation of other DNA-binding proteins. We performed CATCH-IT in Kc167 cells, 
incubating them with media containing azidohomoalanine for four hours after a one hour 
period of methionine starvation, in the presence or absence of NICD. To achieve this, we 
used a cell line where NICD was expressed from the copper-inducible pMT promoter [4] for 
one hour prior to, and during both the methionine starvation and azidohomoalanine 
labeling. Using this approach we detected differential levels of histone turnover, with active 
enhancer regions showing approximately five-fold higher levels of turnover than the 
surrounding less active regions (Fig 5A). Notably, the enriched turnover detected at Su(H)-
binding enhancer regions increased by two to three-fold in the presence of NICD. 
We then tested whether knockdown of the BRM complex would affect the levels of 
nucleosome turnover measured with CATCH-IT. Depletion of Brm by RNAi resulted in a 
localized decrease in histone turnover at the Notch-responsive regions with relatively little 
change at control regions (Fig 5B), strengthening the evidence that the BRM complex has a 
critical role in Notch signaling and providing a specific mechanism by which this may occur. 
Furthermore, Brm depletion had an even greater effect in the Notch-ON condition when 
brm RNAi was combined with copper-inducible NICD expression (Fig 5C), illustrating the 
importance of the BRM complex for the Notch response. 
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Given that we observed increased histone H3.3 recruitment in Notch-ON cells in vivo, we 
next sought to measure the effects on the histone variant H3.3 by expressing V5-tagged 
histone proteins and performing ChIP [51]. When H3-V5 and H3.3-V5 were expressed from a 
constitutive promoter, it was evident that H3.3 predominated over H3 throughout the 
Notch-responsive regions of the E(spl)-C, while the distal region at the E(spl)m8-HLH gene 
had similar levels of both variants (Fig EV4). Neither Notch activity (Fig EV4D and E) nor 
depletion of Brm (Fig EV4F) had a large impact on these distributions of H3 or H3.3, arguing 
that there is no gross change in the overall levels of histones H3 or H3.3 during an acute 
Notch response, and that the BRM complex is not essential for the incorporation of H3.3 per 
se. 
To test the dynamics of the two histone variants in this system, we then expressed H3-V5 
and H3.3-V5 from the pMT promoter so that we could monitor their incorporation over a 
relatively short timescale. By approximately 90 minutes after their induction, the labelled 
histones had started to be incorporated into the chromatin (Fig EV5). By three hours after 
induction, differential incorporation of H3.3-V5 could be observed at specific regions, 
replicating the pattern seen across the E(spl)-C with CATCH-IT, while the levels of H3-V5 
incorporation were lower and largely uniform (Fig 5D). Crucially, the incorporation of H3.3-
V5 was greatly reduced following depletion of Brm, in agreement with the BRM complex 




In summary, we have shown that the BRM chromatin remodeling complex is essential for 
Notch-responsive gene activation. We propose that the BRM complex is required to 
maintain high levels of accessibility at Notch-responsive enhancers where it promotes rapid 
nucleosome turnover. Techniques that measure the nucleosome dynamics were critical in 
uncovering the role of the BRM complex, since the steady state levels of histones bound to 
the DNA do not change. Furthermore, the requirement for the ARP BAP55, whose homolog 
has been implicated in histone eviction [46], lends further support for our model that the 
BRM complex promotes nucleosome turnover. This has two implications for Notch signaling. 
Firstly, in the absence of Notch signaling, the BRM complex brings about local turnover of 
nucleosomes that enables Su(H) to access enhancers with its co-repressors, poising the 
enhancers for activation (Fig 6A). Secondly, BRM is responsible for the dramatic increase in 
chromatin accessibility at responsive genes following Notch activation (Fig 6B). It is possible 
that the BRM complex also plays a key role in switching off the Notch response upon 
cessation of signaling, since the continual turnover of nucleosomes provides a mechanism 
for the rapid resetting of chromatin states. In future, more fine-grained studies will be 
needed to determine precisely which nucleosomes are targeted by BRM complexes and 
what the dynamics of these interactions are.  
 
Our evidence for the involvement of SWI/SNF chromatin remodeling in Notch signaling 
responses, even before signaling takes place, is fully consistent with a previous observation 
that BRM was recruited to Hes1 and Hes5 in mouse myoblasts before Notch induction [52]. 
It also fits with genetic data that hinted at a role for the BRM complex in regulating Notch 
target genes [22]. The fact that an antagonistic effect of Brm on Notch activity has been 
detected in some contexts [24] may be attributed to this role in enabling initial recruitment 
of CSL, as it would bring associated co-repressors [53–55]. Furthermore, since we observe 
consistent effects from inhibiting the BRM complex on Notch-regulated transcription in two 
different contexts, it is likely that the recruitment of SWI/SNF complexes will be a key step in 
selecting enhancer repertoires in different cell types. The SWI/SNF-dependent nucleosome 
turnover is therefore likely to have an integral role in generating accessible enhancer 
landscapes critical for the specificity of signaling pathway responses. To achieve this, BRM 
complexes must be recruited to target enhancers by the cell-type transcription factors that 
confer specificity. Candidates in the case of Notch include Runx and GATA factors which are 
associated with regulated enhancers in blood cell lineages (both in flies and mammals) 
[3,7,56,57]. Similarly, it has been suggested that the pioneer factors GATA3 and FOXA1 are 
required to recruit SWI/SNF complexes to enable binding of the glucocorticoid receptor at 
responsive sites [58]. 
The subsequent role of the BRM complex in bringing about a dramatic change in chromatin 
accessibility at responsive genes following Notch activation is critical for their up-regulation 
(Fig 6B). A striking feature of activated enhancers is that they exhibit a substantial increase 
in certain histone modifications [4,59,60], which could be facilitated by the high level of 
histone turnover that we detect. Indeed, a recent study has found that nucleosome 
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turnover is predictive of the propagation of histone modifications [61]. Furthermore, the 
recruitment of CSL complexes is greatly enhanced following Notch activation [6,7,62] and 
may be an essential step for engaging sufficient low-affinity interactions with Mediator to 
promote active initiation of transcription. We have previously shown that this enhanced 
recruitment involves changes in chromatin accessibility [8] and we now demonstrate that 
the BRM complex is required to enact this change. A similar model has been proposed for 
serum stimulation acting via FOS/JUN, where serum-induced changes in chromatin 
accessibility relied on BRM recruitment [17]. As several studies have shown direct 
interactions between NICD complexes and SWI/SNF subunits in a range of contexts 
[23,24,52], it is plausible that this interaction is responsible for SWI/SNF complex 
recruitment in Notch-ON conditions. Certainly, the BRM complex facilitates the recruitment 
of Su(H) in Notch-ON conditions, as evident from the depleted band of fluorescence in the 
presence of BrmK804R, and most likely does so by promoting nucleosome turnover. The 
final outcome therefore differs in in Notch-ON versus and Notch-OFF conditions, but it 
remains unclear how this is brought about. For example does BRM target different 
nucelosomes or interact with more prolonged dynamics in the Notch-ON state? 
Our results argue therefore that SWI/SNF complexes are likely to play an integral role in 
Notch target enhancer activation. How general this effect of the BRM complex will be is an 
open question – to what extent is SWI/SNF remodeling critical for all types of enhancer 
activity? In the basal state, this complex does not appear to be required in every case, as 
neither heat-shock nor ecdysone-regulated loci exhibited a similar loss of accessibility when 
the BRM complex was perturbed. However, the mammalian SWI/SNF subunit Brg1 is 
required for a robust transcriptional response to glucocorticoid and was found to occupy 
many glucocorticoid response elements prior to hormone treatment [58]. Thus, it has been 
proposed that the selection and activation of hormone-responsive enhancers is reliant on 
the pre-patterning of specialized chromatin environments through the actions of SWI/SNF 
complexes in a similar manner to that proposed here. Elucidating how widely the SWI/SNF 
regulation of nucleosome turnover that we have detected in Notch-responsive regions 
underpins other classes of enhancer activation will be important, especially in the context of 





Materials and Methods 
Fly stocks 
For expression of all UAS constructs in the salivary gland, 1151-Gal4 was used (L S 
Shashidhara, Centre for Cellular and Molecular Biology, Hyderabad, India) [63]. Notch 
signaling was activated by UAS-NΔECD [30,31]. The E(spl)-C was imaged using the ParB-INT 
DNA tagging system where UAS-ParB1-mCherry was expressed in the presence of the INT 
sequence inserted between E(spl)m7-HLH and E(spl)m8-HLH [8,64]. Histone-GFP imaging 
made use of UAS-H3-GFP, UAS-H3.3-GFP and UAS-H3.3core-GFP constructs (flies kindly 
provided by Kami Ahmad) [32,65]. Dynamic H3.3-mKO imaging made use of the UAS-FRT-
H3.3-GFP-PolyA-FRT-H3.3-mKO-PolyA construct crossed with hs-FLP (flies kindly provided by 
Xin Chen) [34]. Su(H) recruitment was monitored using Su(H)-GFP [8]. Dominant negative 
Brm was expressed from UAS-BrmK804R [40]. RNAi lines used are listed in Table 1. 
 
Live imaging of salivary gland nuclei 
Salivary glands were dissected and mounted as described previously [8], using Shields and 
Sang M3 Insect Medium (Sigma S3652) supplemented with 5% FBS (Sigma F9665) and 1x 
Antibiotic-Antimycotic (Gibco 15240062) for dissection and the same medium with the 
addition of 2.5% methyl-cellulose (Sigma) for mounting. For DNA stains, salivary glands were 
incubated in dissecting media containing 200 µg/mL Hoechst 33342 (ThermoFisher) for 10 
minutes at room temperature before washing with PBS and mounting. 
Image acquisition was performed with Nikon D-Eclipse C1 confocal microscope using lasers 
at 405, 488 and 543 nm. Images captured of nuclei used the 60x oil objective with a 4.5x 
zoom level and images of glands used the 40x oil objective. To monitor Su(H)-GFP 
recruitment, nuclei were scanned slowly through the Z-stack using a 2x zoom level while 
looking for accumulations of fluorescence which were scored as bands. The scoring was not 
conducted blind to genotype. However, strict criteria were used to reduce subjective bias: 
the band of fluorescence must be bright, occupy a volume in the z-axis and most 
importantly, persist during microscope scanning. 10 glands and five nuclei per gland were 
analyzed and scored per condition, with the five nuclei closest to the coverslip chosen each 
time. 
For dynamic H3.3-mKO imaging, heat shocks at 37ᵒC were performed on larvae for one hour 
approximately 24 hours before imaging. 24 hours was chosen as a time point shortly after 
the mKO signal was first detectable. Image acquisition was performed with an Olympus 
FV1000 confocal microscope using a 60x/1.35 NA objective with spectral detectors. GFP was 
imaged using a laser at 488nm and subsequently mKO and mCherry were imaged 
simultaneously using a laser at 543nm to excite both fluorophores. The spectral detectors 
were set to detect wavelengths of 555 to 585 nm for mKO and 680 to 750 nm for mCherry. 
These wavelengths were chosen to ensure that the signal from mCherry was not observed 
in the mKO channel. To ensure that the two signals were fully distinguished, the 
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Spectral_Unmixing plugin (Joachim Walter) was used in Fiji [66] to process the images 
before quantification. 
For quantifications of histone-GFP and mKO, representative images where the E(spl)-C could 
be clearly observed were used with the Fiji software [66] as follows. The images were 
rotated such that the E(spl)-C was vertical and a rectangle 1.29 µm by 2.58 µm was placed 
over it, centered on the peak fluorescence of the ParB-mCherry marker. The “plot profile” 
function was used to obtain mean fluorescence intensity across the rectangle in each 
channel. Arbitrary fluorescence values were adjusted such that the highest value obtained 
was set to one and the lowest to zero, and the mean values were taken from several nuclei 
(n numbers given in figure legend). 
 
Immunofluorescence staining 
Staining of salivary glands was performed as described [8] except for the following changes. 
Glands were permeabilized with 1% Triton X-100 in PBS for 30 minutes. Antibodies against 
OSA and BAP170 were gifts from Peter Verrijzer [67] and were used at dilutions of 1:200 and 
1:100 respectively. 
 
Kc167 cell culture, Notch activation and generation of stable lines 
Kc167 cells (Drosophila Genomics Resource Center) were cultured in Schneider’s Drosophila 
medium (Gibco 21720024) supplemented with 5% FBS (Sigma F9665) and 1x Antibiotic-
Antimycotic (Gibco 15240062) at 25ᵒC. Notch was activated either by NICD expression from 
the pMT vector (cell line described below) or by EGTA treatment where media was replaced 
with 4 mM EGTA (Bioworld) in PBS for 30 minutes. 
Stable cell lines were generated by transfection followed by antibiotic selection. 18 µg of the 
relevant plasmid was mixed with 925 µL Opti-MEM (Gibco 31985070) and 54 µL FuGENE HD 
Transfection Reagent (Promega E2311) at room temperature for 30 minutes before adding 
dropwise to cells plated in 10 cm plates. After 24 to 48 hours media was replaced to contain 
antibiotic selection. Cells were grown in the presence of antibiotic and experiments were 
performed after significant cell death and recovery had taken place to indicate selection 
(usually after approximately 3 weeks). 
CATCH-IT was performed in the pMT-NICD cell line generated previously [4], where cells 
were maintained with 2 µg/mL puromycin (Sigma). 
Cell lines expressing BrmWT and BrmK804R were generated using plasmids kindly provided 
by Neus Visa [43]. BrmK804R was re-made by mutagenesis to ensure homogeneity between 
the two constructs using Pfu polymerase with the primers listed in Table 2. The BrmWT and 
BrmK804R sequences were then cloned into the pMT-puro vector (Addgene 17923) by 
digestion with SpeI and PmeI (NEB) and ligation (T4 ligase; Promega). After transfection of 
pMT-BrmWT and pMT-BrmK804R, cells were selected with 5 µg/mL and maintained with 2 
µg/mL puromycin. 
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Constitutive expression of histone-V5 proteins made use of pIB-H3-V5 and pIB-H3.3-V5 
plasmids kindly provided by Dirk Schübeler and used as described [51]. Cells were selected 
with 50 µg/mL and maintained with 20 µg/mL blasticidin (ThermoFisher R21001). For Notch 
activation in these cells, they were further transfected with pMT-NICD and selected then 
maintained with 5 µg/mL and 2 µg/mL puromycin respectively. 
For inducible expression of histone-V5 proteins, H3 and H3.3 sequences were cloned from 
pIB-H3-V5 and pIB-H3.3-V5 into the pMT-puro vector using SpeI and XhoI sites (NEB) with 
the primers listed in Table 2. After transfection of pMT-H3-V5 and pMT-H3.3-V5, cells were 
selected with 5 µg/mL and maintained with 2 µg/mL puromycin. 
To induce expression from all pMT constructs, 5mM CuSO4 was added to normal culture 
media. Induction was performed for 24 hours for experiments with pMT-BrmWT and pMT-
BrmK804R, and for the lengths of time specified for other experiments (see CATCH-IT 
method for details in this experiment). 
 
Assay for transposase-accessible chromatin 
ATAC using salivary glands was performed exactly as described previously with no changes 
[8]. ATAC was performed in Kc167 cells in a similar manner with the following changes. After 
a 30-minute EGTA treatment in 10 cm culture plates containing approximately 40 million 
cells, cells were immediately harvested taking a quarter of the cells for the experiment 
(roughly 10 million). Cells were pelleted at 500xg, 4ᵒC for 5 minutes, washed in 10 mL of 
cold PBS and pelleted again. The cells were then lysed by resuspending in 50 µL lysis buffer 
(10 mM Tris-HCl, pH7.4, 10 mM NaCl, 3 mM MgCl2, 0.3% NP-40), vortexing for 10 seconds, 
keeping on ice for 3 minutes, and vortexing again. Nuclei were pelleted at 400xg, 4ᵒC for 5 
minutes and resuspended in 30 µL TD buffer (Illumina FC-121-1030). 25 µL was used for the 
tagmentation reaction and the rest of the protocol performed exactly as described 
previously for salivary glands [8]. 
 
RNAi in Kc167 cells 
300 to 800 base-pair regions of brm, Snr1 and Bap55 DNA were amplified from genomic 
DNA, with GFP or lacZ sequences amplified from plasmids as controls, using either Q5 or 
Phusion High-Fidelity DNA Polymerases (NEB M0491 and M0530 respectively) and 
overhanging primers containing the T7 promoter sequence listed in Table 2. In vitro 
transcription was performed using the MEGAscript T7 Transcription Kit (Invitrogen 
AM1334). RNA was purified by phenol-chloroform extraction and then annealed to form 
double-stranded RNA by heating to 75ᵒC and cooling slowly. 100 µg double-stranded RNA 
was mixed with 3.5 mL Opti-MEM (Gibco 31985070) and added to approximately 10 million 
cells in a 10 cm plate for 30 minutes before topping up to 10 mL with normal culture 
medium. Volumes were scaled down for some smaller experiments. 
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RNA extraction and reverse transcription 
To extract RNA from Kc167 cells, TRI reagent solution (Invitrogen AM6738) was used 
followed by phenol chloroform extraction and isopropanol precipitation at -20ᵒC overnight. 
For reverse transcription, RNA was resuspended in water and first DNase-treated with the 
DNA-free DNA Removal Kit (Invitrogen AM1906), before reverse transcribing with M-MLV 
Reverse Transcriptase (Promega M1705) using Oligo(dT)15 Primers (Promega C1101). cDNA 
was diluted 5-fold before analysis with qPCR. 




Approximately 20 million Kc167 cells were lysed in 100 µL lysis buffer (50 mM Tris-HCl, 
pH8.0, 150 mM NaCl, 10% glycerol, 0.5% triton X-100) on ice for 30 minutes before debris 
was removed by centrifugation at 13,000xg, 4ᵒC for 30 minutes. Samples were then 
combined with 2x loading buffer (10 mM Tris-HCl, pH6.8, 20% glycerol, 4% SDS, 0.025% 
bromophenol blue, 2% mercaptoethanol) and boiled. Proteins were resolved using standard 
protocols with 15% SDS-PAGE and transferred to nitrocellulose. Blots were probed with 
antibodies against histone H3 (Abcam ab1791) and V5 (Invitrogen R960-25) at dilutions of 
1:1000 and 1:4000 respectively. Horseradish peroxidase-conjugated secondary antibodies 
were used and detected with the ECL system (GE Life Sciences). 
 
Chromatin immunoprecipitation 
Su(H) and V5 ChIP were performed largely as described previously [4,62], using 2.5 µg goat 
Su(H) antibody (Santa Cruz Biotechnology, no longer available) and 1-2 µg V5 antibody 
(Invitrogen R960-25). Briefly, cells were cross-linked with 1% formaldehyde (Sigma F8775) in 
PBS for 10 minutes at 25ᵒC. After lysis, chromatin was diluted 2-fold for sonication and then 
a further 5-fold for pre-clearing with goat or mouse IgG and 40 µL protein G or protein A/G 
PLUS-Agarose (Santa Cruz Biotechnology sc-2002 and sc-2003) for Su(H) and V5 ChIP 
respectively. Immunoprecipitation was performed with 40 µL of the same beads at 4ᵒC 
overnight, followed by washes, elution by vortexing, de-crosslinking with 0.3 M NaCl, 0.1 
mg/mL RNase A and 0.1 mg/mL proteinase K treatment. DNA was purified with the QIAquick 
PCR purification kit (Qiagen) and eluted in 100 µL water for analysis with qPCR. 
 
CATCH-IT 
Schneider’s Drosophila medium without methionine (PAN Biotech), supplemented with 5% 
FBS and 1x Antibiotic-Antimycotic was added to cells for 1 hour, followed by adding either 4 
mM azidohomoalanine (Aha; AnaSpec AS-63669) or 4 mM methionine (Sigma) as a control 
for 4 hours. To activate Notch, pMT-NICD cells were induced with 5 mM CuSO4 for 1 hour 
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before the medium was substituted for methionine-free medium, also containing 5 mM 
CuSO4, so that cells were incubated with CuSO4 for a total of 6 hours. 
CATCH-IT was performed as previously described [50], except where stated otherwise. 
Briefly, cells were harvested and nuclei were extracted with 30 μL of 10% NP-40. Nuclei 
were resuspended in 180 μL of HB125 buffer, and the following were added: 5 μL of 2 nM 
biotin-alkyne (Invitrogen B10185), 10 μL of 100mM THPTA (Sigma 762342) premixed with 2 
μL of 100 mM copper sulfate (Jena Bioscience CLK-M1004), and 6 μL of freshly-prepared 500 
mM sodium ascorbate (Jena Bioscience CLK-M1005). Cycloaddition reaction was performed 
for 30 minutes at room temperature on a rotor. Reaction with MNase (Sigma N3755) was 
performed at 37ᵒC for 3 minutes. After capture with Dynabeads M-280 Streptavidin 
(Invitrogen 11205) as described, captured chromatin and input chromatin samples were 
treated with 0.25 mg/mL RNase A (Roche) and 0.25 mg/mL proteinase K (ThermoFisher). 
DNA was purified with the QIAquick PCR purification kit (Qiagen) and analyzed by qPCR. 
 
qPCR 
All qPCR was performed using LightCycler 480 SYBR Green I Mastermix (Roche 
04707516001) as described previously [8]. For all experiments, two technical replicate qPCR 
reactions were performed per sample and the mean taken for analysis. Replicate numbers 
given in figure legends do not count these technical replicates and instead refer only to 
repeats of the full experimental protocol from start to finish with different cells or animals 
(biological replicates). For reverse transcription experiments, relative amounts of the genes 
of interest were normalized to the control gene RpL32. For ChIP, immunoprecipitated 
samples were normalized to input samples. For CATCH-IT, pulldown samples were 
normalized to input samples and then to the Sec15 transcribed region. All primers used are 
shown in Table 2. 
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Tables 
Table 1 - RNAi lines used. 
RNAi Source1 Phenotype shown in 
published work 
w BL-35573 Used as a control in [8,68] 
Iswi BL-32845 [69] 
Chrac-16 BL-51155 [69] 
MTA1-like BL-33745 [68] 
Ino80 BL-33708 [70] 
Tip60 BL-28563 [71] 
Chd1 BL-34665 [70] 
Chd3 V-13636 Not used previously 
Snr1 BL-32372 [72] 
Moira BL-34919 [73] 
osa (1) BL-31266 [74] 
osa (2) V-7810 [75] 
Bap170 BL-26308 [76] 
polybromo BL-32840 [76] 
Caf1-55 V-26455 [77] (same construct used, 
inserted in a different 
chromosome) 
Caf1-180 BL-28918 [77] 
Dek BL-28696 Not used previously 
yem V-26808 [78] 
zeste BL-31615 Not used previously 
1 Bloomington Drosophila Stock Center is abbreviated BL, and Vienna Drosophila RNAi 
Centre is abbreviated V. 





Histone-V5 cloning into pMT vector 
SpeI_his_forward CCTACTAGTCATGGCTCGTACCAAGCAAACTGC 
XhoI_his_reverse CACCTCGAGGCGGCCGCCACTGTGCTGGATA 













mγ-mβ igr_forward GGAGTTGAGGAGTTGGTCG 
mγ-mβ igr_reverse ATAAGTGTGGTTGGGTGCCT 
mβ tr_forward AGAAGTGAGCAGCAGCCATC 
mβ tr_reverse GCTGGACTTGAAACCGCACC 
mβ enh_forward AGAGGTCTGTGCGACTTGG 
mβ enh_reverse GGATGGAAGGCATGTGCT 
mβ-mα igr_forward AAGCCAGTGGACTCTGCTCT 
mβ-mα igr_reverse TGATCTCCAAGCGGAGTATG 
mα tr_forward GCAGGAGGACGAGGAGGATG 
mα tr_reverse GATCCTGGAATTGCATGGAG 
m2-m3 igr_forward GCGCGTATTTCCCAAATAAA 
m2-m3 igr_reverse GATTGTACGTGCATGGGAAA 
m3 enh_forward ACACACACAAACACCCATCC 
m3 enh_reverse CGAGGCAGTAGCCTATGTGA 
m3 tr_forward CGTCTGCAGCTCAATTAGTC 
m3 tr_reverse AGCCCACCCACCTCAACCAG 
m8 tr_forward CAATTCCACGAAGCACAGTC 
m8 tr_reverse GAGGAGCAGTCCATCGAGTT 
qPCR: additional controls for ATAC 
Rab11 tr_forward ACTGAAAATGGGCCGTTTCG 
Rab11 tr_reverse AGGAGTGGTAATCGACGGTC 
Eip78C enh_forward AGAAGTAGGGGCCGTCAAGT 
Eip78C enh_reverse GTGTAAGACCCGTCGCATTT 
Closed ctrl_forward GCATTTTTGTGGCAGAGGCA 
Closed ctrl_reverse CTCTTTCGGTGTCGCCTTCT 
Mst87F tr_forward ATCCTTTGCCTCTTCAGTCC 
Mst87F tr_reverse AATAATGATACAAAATCTGGTTACGC 
Hsp26 tr_forward TTGAATTCGATCTGTGCTCTGT 
Hsp26 tr_reverse CGGGTATAAAAGCAGCGTCG 
Hsp70 enh_forward TCGTTTTGTGACTCTCCCTCT 
Hsp70 enh_reverse TGTGACAGAGTGAGAGAGCA 
Hr4 enh_forward GGCACCTGACGGTTGATAGT 
Hr4 enh_reverse CAGCCCGAAGAATCTACCAG 
Dip-B tr_forward TCAACTGCAACCGGATGATA 
Dip-B tr_reverse ATAACCTCATCGGCCACGTA 
Eip75B tr_forward AGCAACTTGGCCAGGAACT 
Eip75B tr_reverse AACCTGGAGCTGATCGAGAA 
CTPsyn tr_forward TCGATTGTTGTTGGCTGAGC 
CTPsyn tr_reverse TTCCTTCGCTCTTCCTGTCC 
fru tr_forward CTCTTTCGCACACTTGGCAT 
fru tr_reverse CCGTTCGTTGCCCATCTAAG 
kay tr_forward CTCTCTCATTGGCTCTCCCC 
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kay tr_reverse TGAAGCGGAGACCACACAAT 
vri tr_forward TGTGTGTTTGTGTCTGCGAG 
vri tr_reverse TCACTCACCCTCACCATGAC 





qPCR: additional controls for CATCH-IT 
PPO1 enh_forward AAGTCCCAACCGCAAAACTG 
PPO1 enh_reverse GCTATCGACTAAACCACAACGT 
Him-Her enh_forward CGAACCGAGTTGTGGGAAAT 
Him-Her enh_reverse CCCTTGGAGTGACAATTAGCTG 
Rab11 tr_forward ACTGAAAATGGGCCGTTTCG 
Rab11 tr_reverse AGGAGTGGTAATCGACGGTC 
Sec15 tr_forward GGTAGCGGTTCTCTTGCTTG 
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Figure 1 - H3.3 levels increase at the E(spl)-C in Notch-ON nuclei. 
A, C, E  Live imaging of histone-GFP (green) and ParB-mCherry (magenta) expressed 
in larval salivary gland nuclei using 1151-Gal4. H3.3-GFP levels are increased at the E(spl)-C 
in the presence of constitutively active Notch, NΔECD (Notch-ON), compared to control 
Notch-OFF nuclei expressing LacZ (A). The same is seen with H3.3core-GFP (E), but there is 
little change in H3-GFP between Notch-OFF and Notch-ON nuclei (C). ParB-mCherry binds to 
its cognate int DNA sequence inserted within the E(spl)-C [8,64]. Yellow dotted box contains 
E(spl)-C and yellow arrow indicates position of E(spl)-C on chromosome. Scale bars (white) = 
5 µm. 
B, D, F  Quantifications of relative fluorescence intensity of histone-GFP and ParB-
mCherry across the E(spl)-C in Notch-OFF (upper) and Notch-ON (lower) conditions. 
Mean+/-SEM; nnuclei = 7, 6, 5, 8, 9, 11 and nglands = 5, 5, 5, 5, 5, 4 where each gland represents 
a biological replicate (from top to bottom). 
 
Figure 2 - The BRM complex is required for Su(H) recruitment in Notch-ON nuclei. 
A, C Effects from depleting chromatin remodelers and histone chaperones, as indicated 
(wide range shown in A, BRM complex components shown in C), on recruitment of Su(H)-
GFP in Notch-ON nuclei (expressing NΔECD) of larval salivary glands. w RNAi is a control and 
BrmK804R is expression of dominant-negative Brm. Different OSA RNAi stocks used in C are 
denoted by (1) and (2). In all conditions except Moira RNAi (A), Snr1 RNAi and BrmK804R 
expression (C), nuclei exhibit a bright accumulation of Su(H)-GFP at a single locus when 
imaged live. Scale bars (yellow) = 5 µm. 
B, D Percentage of Notch-ON nuclei retaining a single clear band of Su(H)-GFP when the 
indicated RNAi is co-expressed with NΔECD. For each genotype, 5 nuclei from each of 10 
glands were scored (50 nuclei total). **** A significant fraction of nuclei lost the fluorescent 
band when core components of the BRM complex were perturbed; p<0.0001, two-tailed 
Fisher’s exact test calculated using the raw (non-percentage) scoring data. 
 
Figure 3 - The BRM complex is required for chromatin accessibility at Notch-responsive 
regions. 
A Genomic region encompassing the E(spl)-C; green graphs indicate ChIP enrichment 
for Su(H) in Kc167 cells (Log2 scale is -0.5 to 2.9, data published previously in [4]); gene 
models are depicted in dark blue. Positions of primer pairs used in qPCR experiments are 
indicated with black arrows. Abbreviations are as follows: “igr” = intergenic region, “tr” = 
transcribed region and “enh” = enhancer. 
B, C Chromatin accessibility in Notch-OFF (B) and Notch-ON (NΔECD expression, C) salivary 
gland nuclei measured by ATAC-qPCR; fold enrichment at the indicated regions compared to 
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a “closed ctrl” region. Expression of dominant-negative Brm, BrmK804R, led to reduced 
accessibility of E(spl)mβ-HLH and E(spl)m3-HLH enhancer regions in Notch-OFF conditions, 
and to a more widespread reduction in accessibility in Notch-ON conditions. “Eip78C enh” 
corresponds to the ecdysone receptor-binding region of the Eip78C enhancer, which is 
highly accessible but not Notch-responsive; “Rab11 tr” and “Mst87F tr” represent highly and 
lowly-expressed control genes respectively. Mean +/- SEM; n = 3; * p<0.05 with two-tailed 
Welch’s t-test comparing LacZ and BrmK804R samples. 
D Chromatin accessibility in salivary gland nuclei depleted for Su(H) by RNAi, measured 
by ATAC-qPCR; fold enrichment at the indicated regions compared to a “closed ctrl” region. 
Accessibility is increased across most of the E(spl)-C compared to controls expressing LacZ. 
Control primer regions are as in B and C. Mean +/- SEM; n = 3; * p<0.05 with two-tailed 
Welch’s t-test compared to LacZ controls. 
 
Figure 4 - The BRM complex is required for Su(H) recruitment and Notch-dependent 
transcription in Kc167 cells. 
A Effect of brm and Snr1 RNAi on brm and Snr1 cDNA levels respectively, measured by 
reverse transcription-qPCR in Kc167 cells; percentage cDNA compared to GFP RNAi. The 
knockdowns are highly effective, with only 1-2% of brm and Snr1 cDNA remaining 
detectable. Mean +/- SEM; n = 3. 
B, C Knockdown of components of the BRM complex reduces Su(H) recruitment both in 
Notch-OFF (B) and Notch-ON (C) conditions. Fold enrichment of Su(H) occupancy at the 
indicated positions detected by ChIP, relative to input, in Kc167 cells treated with brm, Snr1 
or GFP RNAi as a control. Notch-ON conditions (C) were induced by 30 minutes of EGTA 
treatment. Mean +/- SEM, n = 3 (B); Mean, n = 2 (C); * p<0.05 with one-tailed student’s t-
test compared to GFP RNAi control. 
D Effect of brm RNAi on E(spl)mβ-HLH (mβ) and E(spl)m3-HLH (m3) induction by Notch 
activation (EGTA treatment) measured by reverse transcription-qPCR; shown as fold 
difference to lacZ RNAi control. Mean +/- SEM; n = 3. 
E Effect of Brm dominant-negative on expression of E(spl)mβ-HLH (mβ) and E(spl)m3-
HLH (m3) measured by reverse transcription-qPCR. Expression was analyzed in stable cell 
lines containing pMT-inducible BrmWT or BrmK804R in the absence (left, uninduced) or 
presence of copper sulfate (right, Cu2+ induced). The response of E(spl)mβ-HLH and 
E(spl)m3-HLH to Notch activation (“N-On” = EGTA treatment vs. “N-Off” = PBS control) was 
reduced in the BrmK804R-expressing cells compared to BrmWT-expressing cells, only when 
induced with copper (right graph). Mean, n = 2 (left); Mean +/- SEM, n = 3 (right); * p<0.05 
with one-tailed student’s t-test comparing BrmWT and BrmK804R. 
F Knockdown of actin-related subunit, BAP55, reduces Su(H) recruitment in both 
Notch-OFF (PBS treatment) and Notch-ON (EGTA treatment) conditions. Fold enrichment of 
Su(H) occupancy at the indicated positions detected by ChIP, relative to input, in Kc167 cells 
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treated with Bap55 or lacZ RNAi as a control. Mean +/- SEM; n = 3; * p<0.05 with one-tailed 
student’s t-test compared to lacZ RNAi control. 
G Effect of Bap55 RNAi on E(spl)mβ-HLH (mβ) and E(spl)m3-HLH (m3) expression levels 
measured by reverse transcription-qPCR in Notch-OFF (PBS treatment) and Notch-ON (EGTA 
treatment) conditions. Expression level of RpII215 is shown as a control gene. Mean +/- 
SEM; n = 3; * p<0.05 with one-tailed student’s t-test compared to lacZ RNAi control. 
 
Figure 5 - Nucleosome turnover at Su(H)-bound enhancers is increased in Notch-ON cells 
and is dependent on the BRM complex. 
A Nucleosome turnover measured by CATCH-IT-qPCR; fold enrichment over input 
samples compared to Sec15 tr control region. Su(H)-bound enhancers show increased 
nucleosome turnover in response to Notch signaling. Notch signaling is activated in Kc167 
cells by 6 hours of copper induction of pMT-NICD with copper excluded in the control. 
Positions of E(spl)-C primers are shown in Fig 3A; the remaining primers are control non-
Notch-responsive regions. Mean, n = 2. 
 B brm RNAi reduces nucleosome turnover at Notch-responsive regions. CATCH-IT-qPCR 
results as in A after brm or lacZ RNAi as a control. Mean +/- SEM; n = 5; * p<0.05 with one-
tailed student’s t-test comparing brm and lacZ RNAi. 
C Brm is required for Notch-responsive nucleosome turnover. CATCH-IT-qPCR results 
after brm or lacZ RNAi as in B and pMT-NICD expression as in A. Mean +/- SEM; n=3; * 
p<0.05 with two-tailed student’s t-test compared to control (lacZ RNAi Notch-ON bars are 
compared to lacZ RNAi Notch-OFF bars and brm RNAi bars are compared to their respective 
lacZ RNAi control bars). 
D brm RNAi reduces incorporation of histone H3.3. V5 ChIP-qPCR in Kc167 cells after 
lacZ or brm RNAi treatment in cells with H3-V5 or H3.3-V5 expression induced from the pMT 
promoter by 3 hours of copper treatment, shown as fold enrichment over input samples. 
Mean +/- SEM; n = 3. * p<0.05 with two-tailed Welch’s t-test compared to lacZ RNAi control. 
 
Figure 6 - Model of BRM complex action. 
A In the absence of Notch signaling, the BRM complex maintains the accessibility of 
Notch-responsive enhancers to allow Su(H) recruitment by promoting nucleosome turnover. 
B When Notch signaling is activated, the nucleosome turnover at Notch-responsive 
enhancers increases, increasing the accessibility of the chromatin and allowing more Su(H) 




Expanded View Figure Legends 
Figure EV1 - Histone H3.3 is incorporated dynamically at the E(spl)-C in Notch-ON nuclei. 
A Live imaging of H3.3-GFP (green), H3.3-mKO (magenta) and ParB-mCherry (cyan) 
expressed in larval salivary gland nuclei using 1151-Gal4 with the UAS-FRT-H3.3-GFP-PolyA-
FRT-H3.3-mKO-PolyA transgene [34]. H3.3-mKO expression was initiated by heat shock-
inducible flippase expression approximately 24 hours before imaging (see Methods for 
details), and ParB-mCherry indicates the E(spl)-C as in Fig 1. H3.3-mKO incorporation shows 
a similar pattern to H3.3-GFP in Notch-OFF (LacZ expression) and Notch-ON (NΔECD 
expression) nuclei, as higher levels are present relative to surrounding regions in the Notch-
ON condition. Yellow arrow indicates position of E(spl)-C on chromosome. Scale bars (white) 
= 5 µm. 
B Quantifications of relative fluorescence intensity of H3.3-GFP, H3.3-mKO and ParB-
mCherry across the E(spl)-C in Notch-OFF (upper) and Notch-ON (lower) conditions. 
Mean+/-SEM; nnuclei = 3, 5 and nglands = 3, 3 where each gland represents a biological 
replicate (from top to bottom). 
 
Figure EV2 - The RNAi lines used successfully reduce RNA and protein levels. 
A, B Effects of the indicated RNAi expression in salivary glands on cDNA levels, measured 
by reverse transcription-qPCR; percentage cDNA compared to w RNAi control after 
normalizing to an internal control for each sample (RpL32 for most but RpII215 for Moira as 
Moira RNAi appeared to affect RpL32 levels). All reduce their respective cDNA levels, with 
polybromo RNAi causing a greater reduction than Snr1, despite not having an effect on 
Su(H) recruitment (B). Note that samples included RNA extracted from adjoining fat cells as 
well as salivary glands, and thus some variability in the knockdowns is attributed to residual 
expression of chromatin remodelers and chaperones in the fat tissue where the RNAi was 
not expressed. Mean, n = 2. 
C Live Hoechst 33342 staining (blue) of salivary glands expressing either w RNAi or 
BrmK804R. Chromosomes are observed with distinctive banding patterns under both 
conditions despite chromosomes being slightly smaller with BrmK804R expression. Scale 
bars (white) = 5 µm. 
D, F Immunofluorescence staining of OSA (C; magenta) and BAP170 (E; magenta) in 
salivary glands expressing osa (stock (2) in Fig 2) and Bap170 RNAi respectively, compared to 
w RNAi control glands. osa RNAi depletes all detectable OSA protein and Bap170 RNAi 
removes most BAP170 protein. Yellow arrows indicate salivary gland nuclei and yellow 
arrowheads indicate fat cell nuclei for comparison where RNAi is not expressed. Scale bars 
(white) = 50 µm. 
E, G Quantifications of OSA (E) and BAP170 (G) nuclear levels from maximum projection 
images with salivary gland nuclei normalized to fat cell nuclei. 
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Figure EV3 - The effects of BrmK804R on the accessibility and expression of Notch-
inducible genes are not widespread. 
A, B Chromatin accessibility in Notch-OFF (A) and Notch-ON (NΔECD expression, B) salivary 
gland nuclei measured by ATAC-qPCR; fold enrichment at the indicated regions compared to 
a “closed ctrl” region. Expression of dominant-negative Brm, BrmK804R, had little effect or 
increased the accessibility of some regions. “Hsp26 tr” and “Hsp70 enh” are heat shock-
responsive regions, while “Hr4 enh”, “Dip-B tr” and “Eip75B” are ecdysone-responsive. 
“Rab11 tr”, “Eip78C”, “Closed ctrl” and “Mst87F tr” are the same as shown in Fig 3B and C. 
Mean +/- SEM; n = 3. 
C Effect of Notch activation (NΔECD versus LacZ expression) and BrmK804R expression 
on gene expression in salivary glands measured by reverse transcription-qPCR. Genes shown 
are Notch-responsive E(spl)mβ-HLH  (mβ) and E(spl)mα-HLH (mα), housekeeping gene 
RpII215, and ecdysone-responsive Dip-B and Eip75B. Out of those shown, BrmK804R 
expression only reduces the Notch-responsive expression of E(spl)mβ-HLH and E(spl)mα-
HLH. Mean, n = 2. 
D Effect of Su(H) RNAi expression on Su(H)-GFP levels detected with live imaging 
compared to LacZ expression control. No Su(H)-GFP was left detectable and this genotype 
was used for the ATAC experiment in Fig 3D. Scale bars (yellow) = 50 µm. 
E An acute Notch response in Kc167 cells involves increased enhancer accessibility. 
Chromatin accessibility across the E(spl)-C in Notch-ON (EGTA-treated) and Notch-OFF (PBS 
control) Kc167 cells detected by ATAC-qPCR. Fold enrichment of the indicated regions 
compared to a “closed ctrl” region; positions of E(spl)-C primers in the genome are shown in 
Fig 3A. “CTPsyn tr”, “fru tr”, “kay tr” and “vri tr” are highly accessible control regions which 
do not respond to Notch. Mean +/- SEM; n = 3. 
 
Figure EV4 - Notch activation does not affect the distribution of histones H3 and H3.3. 
A H3-V5 and H3.3-V5 expression in stable cell lines compared to un-transfected “Kc 
cells”, demonstrated by Western blots probed with H3 and V5 antibodies. V5-tagged 
histones have a larger molecular weight and are not detectable in the H3 blot due to low 
levels of expression in comparison to endogenous H3. 
B, C Effect of Notch activation by EGTA (B) or copper-inducible NICD expression (C) on 
expression of E(spl)mβ-HLH and E(spl)m3-HLH in stable cell lines expressing H3-V5 and H3.3-
V5, measured by reverse transcription-qPCR. Both methods of activation strongly induce 
both genes. “N-On” denotes EGTA or copper treatment and “N-Off” denotes PBS alone or 
no copper. 
D, E Notch activation does not affect H3 and H3.3 levels across the E(spl)-C. V5 ChIP-qPCR 
in Kc cells expressing H3-V5 or H3.3-V5 from a ubiquitous promoter with Notch signaling 
activated by EGTA (D) or 6 hours of copper-inducible NICD expression (E), shown as fold 
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enrichment over input samples. H3-V5 and H3.3-V5 show a differential pattern across the 
E(spl)-C but Notch activation causes no detectable change in levels compared to controls 
treated with PBS (D) or no copper (E). Mean +/- SEM, n = 3 (D); Mean, n = 2 (E). 
F V5 ChIP-qPCR in Kc cells expressing H3-V5 or H3.3-V5 from a ubiquitous promoter 
after lacZ or brm RNAi treatment, shown as fold enrichment over input samples. The 
changes caused by brm RNAi are minimal and do not occur at enhancer regions. Mean +/- 
SEM; n = 3. 
 
Figure EV5 - Time-course of copper-inducible histone-V5 expression. 
A-D V5 ChIP-qPCR in Kc cells with H3-V5 and H3.3-V5 expression induced by copper from 
the pMT promoter for 60 minutes (A), 90 minutes (B), 3 hours (C) and 24 hours (D), shown 
as fold enrichment over input samples. Differential incorporation of H3.3 across the E(spl)-C 
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